- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Crizotinib – November 2017
Crizotinib: Capsule 200 mg, Capsule 250 mg; Xalkori®
Last updated
16 March 2018